TY - JOUR
T1 - Psychopathological disorders in Prader-Willi syndrome
AU - Guinovart, Martí
AU - Coronas, Ramón
AU - Caixàs, Assumpta
PY - 2019/11/1
Y1 - 2019/11/1
N2 - © 2019 SEEN y SED Prader-Willi syndrome is a genetic disorder caused by chromosomal changes in segment 15q11-q13 including cognitive, mental, and behavioral symptoms, as well as a specific physical phenotype. Both the most common psychopathological changes (intellectual disability, obsessions, impulsivity, autism spectrum disorders, self-injuries) and the main psychiatric comorbidities (affective disorders, psychosis, obsessive-compulsive disorder, autism spectrum disorder) are characterized by a great heterogeneity, which warrants the need for better identification of their frequency and clinical signs. In addition to its effects on body compositionand hypotony, growth hormone has been shown to be useful for regulating patient behavior, and psychoactive drugs are also an option. Other alternatives have shown promising results in experimental trials. Adequate understanding of the psychopathology associated to Prader-Willi syndrome would allow for improving clinical approach, symptom identification, detection of comorbidities, and administration of more effective treatments, leading to better clinical outcomes.
AB - © 2019 SEEN y SED Prader-Willi syndrome is a genetic disorder caused by chromosomal changes in segment 15q11-q13 including cognitive, mental, and behavioral symptoms, as well as a specific physical phenotype. Both the most common psychopathological changes (intellectual disability, obsessions, impulsivity, autism spectrum disorders, self-injuries) and the main psychiatric comorbidities (affective disorders, psychosis, obsessive-compulsive disorder, autism spectrum disorder) are characterized by a great heterogeneity, which warrants the need for better identification of their frequency and clinical signs. In addition to its effects on body compositionand hypotony, growth hormone has been shown to be useful for regulating patient behavior, and psychoactive drugs are also an option. Other alternatives have shown promising results in experimental trials. Adequate understanding of the psychopathology associated to Prader-Willi syndrome would allow for improving clinical approach, symptom identification, detection of comorbidities, and administration of more effective treatments, leading to better clinical outcomes.
KW - Comorbidity
KW - Prader-Willi syndrome
KW - Psychopathology
UR - http://www.mendeley.com/research/psychopathological-disorders-praderwilli-syndrome
U2 - 10.1016/j.endinu.2019.03.004
DO - 10.1016/j.endinu.2019.03.004
M3 - Review article
C2 - 31006652
SN - 2530-0164
VL - 66
SP - 579
EP - 587
JO - Endocrinologia, Diabetes y Nutricion
JF - Endocrinologia, Diabetes y Nutricion
IS - 9
ER -